|
[1] 中华医学会.慢性乙型肝炎防治指南[J].中华内科杂志, 2006, 45 (2) :162-170.
|
|
[2]朱启镕.乙肝病毒母婴传播产前阻断的研究进展[J].中华妇幼医学杂志 (电子版) , 2006, 2 (1) :48-49.
|
|
[3]Chan CY, Lee SD, Lo KJ.Legend of hepatitis B vaccination:theTaiwan experience[J].J Gastroenterol Hepatol, 2004, 19 (2) :121-126.
|
|
[4]Chien YC, Jan CF, Kuo HS, et al.Nationalwide hepatitis Bvaccination program in Taiwan:effectiveness in the 20 years after itwas launched[J].Epidemiol Rev, 2006, 28:126-135.
|
|
[5]Liang SF, Bi SL, Yang WZ, et al.Epidemiological serosurvery ofHepatitis B in China-Decling HBV prevalence due to Hepatitis Bvaccination[J].Vaccine, 2009, 27 (47) :6550-6557.
|
|
[6]Fattovich G.Natural history of hepatitis B[J].J Hepatol, 2003, 39:S50-S58.
|
|
[7]Yim HJ, Lok AS.Natural history of chronic hepatitis B virusinfection:what we knew in 1981 and what we know in 2005[J].Hepatology, 2006, 43 (2 Suppl 1) :S173-181.
|
|
[8]张鸿飞, 朱世殊, 杨晓晋, 等.小儿乙、丙型肝炎临床与病理研究[J].传染病信息, 2006, 19 (3) :130-131.
|
|
[9]陈慧, 朱启镕, 王建设.免疫预防后经胎盘传递的乙型肝炎病毒标志及动态观察[J].中华传染病杂志, 2004, 22 (5) :335-336.
|
|
[10]Hongthanakorn C, Lok AS.New pharmacologic therapies in chronic hepatitis B[J].Gastroenterol Clin North Am, 2010, 39 (3) :659-680.
|
|
[11]Jonas MM, Kelly D, Pollack H, et al.Safety, efficacy, andpharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to<18 years) with chronic hepatitis B[J].Hepatology, 2008, 47 (6) :1863-1871.
|
|
[12]张鸿飞.儿童慢性乙型肝炎抗病毒治疗的时机与方案选择[J].中国实用儿科杂志, 2010, 25 (12) :903-905.
|
|
[13]王建设.儿童慢性乙型肝炎抗病毒治疗新进展[J].中华临床感染病杂志, 2010, 3 (1) :57-60.
|
|
[14]俞蕙.儿童慢性乙型肝炎的干扰素-α治疗[J].中国实用儿科杂志, 2010, 25 (12) :907-909.
|
|
[15]Jonas MM, Mizerski J, Badia IB, et al.Clinical trial of lamivudine inchildren with chronic hepatitis B[J].N Engl J Med, 2002, 346 (22) :1706-1713.
|
|
[16]Sokal E, Kelly D, Mizerski J, et al.Long-term lamivudine therapyfor children with HBeAg-positive chronic hepatitis B[J].Hepatology, 2006, 43 (2) :225-232.
|
DownLoad: